Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$354M |
| 2 |
Verizon
VZ
|
+$307M |
| 3 |
HCA Healthcare
HCA
|
+$256M |
| 4 |
Marathon Petroleum
MPC
|
+$239M |
| 5 |
Comcast
CMCSA
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$361M |
| 2 |
Texas Instruments
TXN
|
+$333M |
| 3 |
LyondellBasell Industries
LYB
|
+$305M |
| 4 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$298M |
| 5 |
Northrop Grumman
NOC
|
+$282M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.44% |
| 2 | Technology | 18.54% |
| 3 | Consumer Discretionary | 14.07% |
| 4 | Industrials | 10.25% |
| 5 | Financials | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
TripAdvisor
TRIP
$1.19B
| $10.7M | 0.01% |
199,214
+74,444
| +60% | +$4.12M |
|
702
Carlisle Companies
CSL
$14.4B
| $10.7M | 0.01% |
106,841
-12,941
| -11% | -$1.33M |
|
703
Dolby
DLB
$6.19B
| $10.7M | 0.01% |
173,292
-88,950
| -34% | -$5.99M |
|
704
Vera Bradley
VRA
$90.1M
| $10.7M | 0.01% |
1,247,102
+84,754
| +7% | +$995K |
|
|
MTOR
705
DELISTED
MERITOR, Inc.
MTOR
| $10.6M | 0.01% |
626,587
-203,689
| -25% | -$3.47M |
|
706
McGrath RentCorp
MGRC
$2.85B
| $10.6M | 0.01% |
205,748
-3,522
| -2% | -$181K |
|
707
Ferrari
RACE
$74.6B
| $10.6M | 0.01% |
106,669
-12,477
| -10% | -$1.4M |
|
|
GTS
708
DELISTED
Triple-S Management Corporation
GTS
| $10.6M | 0.01% |
639,427
-105,864
| -14% | -$1.83M |
|
709
Weyerhaeuser
WY
$17.6B
| $10.5M | 0.01% |
479,395
-289,507
| -38% | -$7.71M |
|
710
Penske Automotive Group
PAG
$14.3B
| $10.5M | 0.01% |
259,907
-10,225
| -4% | -$442K |
|
711
Hancock Whitney
HWC
$6.01B
| $10.4M | 0.01% |
300,907
+18,334
| +6% | +$743K |
|
712
Progress Software
PRGS
$1.78B
| $10.4M | 0.01% |
293,135
-11,571
| -4% | -$386K |
|
713
Autodesk
ADSK
$53.7B
| $10.3M | 0.01% |
80,245
+18,656
| +30% | +$2.52M |
|
|
CRCM
714
DELISTED
CARE.COM, INC.
CRCM
| $10.3M | 0.01% |
533,913
-49,246
| -8% | -$895K |
|
715
Citi Trends
CTRN
$619M
| $10.3M | 0.01% |
505,610
-44,861
| -8% | -$1.06M |
|
716
Barrett Business Services
BBSI
$810M
| $10.3M | 0.01% |
717,496
+20,164
| +3% | +$326K |
|
717
International Bancshares
IBOC
$4.45B
| $10.2M | 0.01% |
295,938
-11,560
| -4% | -$445K |
|
718
Insight Enterprises
NSIT
$4.26B
| $10.2M | 0.01% |
249,795
-14,474
| -5% | -$667K |
|
719
Trinity Industries
TRN
$2.37B
| $10.1M | 0.01% |
492,208
-523,370
| -52% | -$12.1M |
|
720
Greif
GEF
$4.89B
| $10.1M | 0.01% |
272,703
+10,480
| +4% | +$490K |
|
721
Roper Technologies
ROP
$41.1B
| $10.1M | 0.01% |
37,939
+617
| +2% | +$174K |
|
|
NXGN
722
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $10.1M | 0.01% |
667,146
+37,218
| +6% | +$638K |
|
723
Lincoln Electric
LECO
$15.4B
| $10.1M | 0.01% |
128,092
+100,909
| +371% | +$8.38M |
|
724
STAAR Surgical
STAA
$1.17B
| $10.1M | 0.01% |
316,388
-141
| -0% | -$5.49K |
|
725
Vericel Corp
VCEL
$2.17B
| $10.1M | 0.01% |
579,403
+247,860
| +75% | +$3.71M |
|
Similar funds
Cliff Asness's Q4 2018 Portfolio in Review
As of Q4 2018, Cliff Asness held 2,392 positions worth $86.3B, down 17% from $105B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Cliff Asness's Q4 2018 filing shows 138 new, 818 increased, 1,174 reduced and 217 closed positions. Its largest new stake was Linde: 705,153 shares worth $111M. The largest sale was Intel, an estimated $361M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
- Cliff Asness's largest Q4 2018 buy was Linde: 705,153 shares worth $111M.
- Cliff Asness added most to Merck in Q4 2018, an estimated $354M increase.
- Cliff Asness's biggest Q4 2018 reduction was Intel, cutting an estimated $361M.
- Cliff Asness fully exited Aetna Inc in Q4 2018, selling an estimated $104M.
- Cliff Asness's ten largest holdings make up 13% of its $86.3B portfolio in Q4 2018.
- Cliff Asness opened 138 new positions and closed 217 in Q4 2018.
- Cliff Asness's portfolio value fell 17% quarter-over-quarter to $86.3B.
Based on AQR Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.